Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TEAD4 | Q15561 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | ACHE | P22303 | 2/20 | 0.44 |
| ▸ | MMP13 | P45452 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | HTR2A | P28223 | 2/20 | 0.42 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | BCHE | P06276 | 1/20 | 0.40 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.39 |
| ▸ | FNTA | P49354 | 1/20 | 0.39 |
| ▸ | FNTB | P49356 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21303292 | 0.94 | TEAD4 (0.54) | TEAD4ALDH1A1TDP1POLBMAPT | |
| SCHEMBL12642916 | 0.94 | TEAD4 (0.54) | TEAD4ALDH1A1TDP1POLBMAPT | |
| SCHEMBL4366979 | 0.90 | ALDH1A1 (0.48) | TEAD4ALDH1A1TDP1POLBMAPT | |
| SCHEMBL15849015 | 0.90 | ALDH1A1 (0.48) | TEAD4ALDH1A1TDP1POLBMAPT | |
| Diphenylether SCHEMBL27288324 | 0.89 | HTT (0.52) | TEAD4ALDH1A1TDP1POLBMAPT | |
| SCHEMBL10030391 | 0.87 | TEAD4 (0.47) | TEAD4ALDH1A1TDP1POLBMAPT | |
| SCHEMBL14823817 | 0.86 | TEAD4 (0.54) | TEAD4ALDH1A1TDP1POLBMAPT | |
| SCHEMBL18409817 | 0.86 | TEAD4 (0.54) | TEAD4ALDH1A1TDP1POLBMAPT | |
| SCHEMBL22434556 | 0.86 | ALDH1A1 (0.50) | TEAD4ALDH1A1TDP1POLBMAPT | |
| SCHEMBL22404378 | 0.86 | ALDH1A1 (0.50) | TEAD4ALDH1A1TDP1POLBMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250368595-A1 | NOVEL MOLECULES | Xeniopro GmbH (DE) | 2025-12-04 | — | — | US | claimed |
| US-20250368595-A1 | NOVEL MOLECULES | Xeniopro GmbH (DE) | 2025-12-04 | — | — | US | disclosed |
| US-12030855-B2 | Process for making amino diaryl ethers and amino diaryl ethers hydrochloride salts | CELLESTIA BIOTECH AG (CH) | 2024-07-09 | — | — | US | disclosed |
| US-20230141913-A2 | PHENOXY(HETERO)ARYL ETHERS OF ANTIPROLIFERACTIVE ACTIVITY | Xeniopro GmbH (DE) | 2023-05-11 | — | — | US | disclosed |
| US-20220249500-A1 | PHENOXY(HETERO)ARYL ETHERS OF ANTIPROLIFERACTIVE ACTIVITY | Xeniopro GmbH (DE) | 2022-08-11 | — | — | US | disclosed |
| US-10988596-B2 | Method for stabilising a composition made from poly(arylene-ether-ketone) (PAEK) | ARKEMA FRANCE (FR) | 2021-04-27 | — | — | US | disclosed |
| WO-2020246566-A1 | MAIN CHAIN SCISSION-TYPE RESIST MATERIAL AND COMPOSITION COMPRISING SAME | 株式会社日本触媒 | 2020-12-10 | — | — | WO | disclosed |
| US-10815420-B2 | Proppant comprising a crosslinked polymer for treatment of subterranean formations | HALLIBURTON ENERGY SERVICES, INC. (US) | 2020-10-27 | — | — | US | disclosed |
| EP-3086316-B1 | SOUND ABSORBING AND INSULATING MATERIAL AND METHOD FOR MANUFACTURING THE SAME | HYUNDAI MOTOR CO LTD (KR) | 2019-07-31 | — | — | EP | disclosed |
| US-10329270-B2 | Heteroaryl compounds as BTK inhibitors and uses thereof | MERCK PATENT GMBH (DE) | 2019-06-25 | — | — | US | disclosed |
| US-20100252818-A1 | PHOSPHAPHENANTHRENE COMPOUNDS AND ORGANIC LIGHT EMITTING DIODE USING THE SAME | INKTEC CO., LTD. (KR) | 2010-10-07 | — | — | US | disclosed |
| US-7645741-B2 | Inhibitors of apoptosis proteins (IAP); antiproliferative agents; anticancer agents; bioavailability; coupling; chemical intermediates | AEGERA THERAPEUTICS, INC. | 2010-01-12 | — | — | US | disclosed |
| US-20090326003-A1 | PYRAZOLO (3, 4-B) PYRIDINE DERIVATIVES AS PDE4 INHIBITORS | GLAXO GROUP LIMITED (GB) | 2009-12-31 | — | — | US | disclosed |
| US-7462625-B2 | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto | NEUROCRINE BIOSCIENCES, INC. (US) | 2008-12-09 | — | — | US | disclosed |
| US-20080207525-A1 | Inhibitors of apoptosis proteins (IAP); antiproliferative agents; anticancer agents; bioavailability; coupling; chemical intermediates | PHARMASCIENCE INC. (CA) | 2008-08-28 | — | — | US | disclosed |
| US-20070208049-A1 | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto | NEUROCRINE BIOSCIENCES, INC. (US) | 2007-09-06 | — | — | US | disclosed |
| US-20070042202-A1 | Double-sided metallic laminate and method for manufacturing the same | LG CHEM, LTD. (KR) | 2007-02-22 | — | — | US | disclosed |
| US-7179815-B2 | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto | NEUROCRINE BIOSCIENCES, INC. (US) | 2007-02-20 | — | — | US | disclosed |
| US-7179815-B2 | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto | NEUROCRINE BIOSCIENCES, INC. (US) | 2007-02-20 | — | — | US | disclosed |
| US-7166603-B2 | Dihydropyrimidone inhibitors of calcium channel function | BRISTOL-MYERS SQUIBB CO. (US) | 2007-01-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090326003-A1 | PYRAZOLO (3, 4-B) PYRIDINE DERIVATIVES AS PDE4 INHIBITORS | PDE4A, PDE4B, PDE12 | TEAD4 1079/4885ALDH1A1 692/4885TDP1 713/4885 |
| US-20220249500-A1 | PHENOXY(HETERO)ARYL ETHERS OF ANTIPROLIFERACTIVE ACTIVITY | AHR, MUSK, TYR | TEAD4 81/4885ALDH1A1 1806/4885TDP1 1357/4885 |
| US-20100252818-A1 | PHOSPHAPHENANTHRENE COMPOUNDS AND ORGANIC LIGHT EMITTING DIODE USING THE SAME | DDT, PPOX, ODC1 | TEAD4 2267/4885ALDH1A1 923/4885TDP1 2028/4885 |
| US-20250368595-A1 | NOVEL MOLECULES | MUSK, IKZF3, TYR | TEAD4 647/4885ALDH1A1 950/4885TDP1 1546/4885 |
| US-20230141913-A2 | PHENOXY(HETERO)ARYL ETHERS OF ANTIPROLIFERACTIVE ACTIVITY | AHR, MUSK, TYR | TEAD4 81/4885ALDH1A1 1806/4885TDP1 1357/4885 |
| US-20080207525-A1 | Inhibitors of apoptosis proteins (IAP); antiproliferative agents; anticancer agents; bioavailability; coupling; chemical intermediates | BIRC5, XIAP, BAX | TEAD4 1130/4885ALDH1A1 3619/4885TDP1 676/4885 |
| US-20070208049-A1 | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto | GNRHR, GHRHR, LHCGR | TEAD4 4828/4885ALDH1A1 3443/4885TDP1 2695/4885 |
| US-12030855-B2 | Process for making amino diaryl ethers and amino diaryl ethers hydrochloride salts | ADH1C, ADH1A, DDC | TEAD4 2691/4885ALDH1A1 42/4885TDP1 3274/4885 |
| US-10329270-B2 | Heteroaryl compounds as BTK inhibitors and uses thereof | BTK, SYK, LCK | TEAD4 2074/4885ALDH1A1 4570/4885TDP1 1162/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.